Longitudinal quantification of aqueous flare and cells in Vogt-Koyanagi-Harada disease

British Journal of Ophthalmology

Volumn 92, Issue 2, 2008, Pages 182-185

  Fang, W ^a,b   Zhou, H ^a,b   Yang, P ^a,b   Huang, X ^a,b   Wang, L ^a,b   Kijlstra, A ^b,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CORTICOSTEROID; CYCLOSPORIN;

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; HUMAN; IMMUNOTHERAPY; LASER FLARE CELL METER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; SCHOOL CHILD; VOGT KOYANAGI SYNDROME;

ADOLESCENT; ADULT; AQUEOUS HUMOR; BLOOD-AQUEOUS BARRIER; CELL COUNT; CHILD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 38949208824     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.128967     Document Type: Article

References (27)

1. Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 1995;39:265-92.
2. Read RW, Rechodouni A, Butani N, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2001;131:599-606.
3. Forster DJ, Cano MR, Green RL, et al. Echographic features of the Vogt-Koyanagi-Harada syndrome. Arch Ophthalmol 1990;108:1421-6.
4. Murakami S, Inaba Y, Mochizuki M, et al. A nation-wide survey on the occurrence of Vogt-Koyanagi-Harada disease in Japan [in Japanese]. Nippon Ganka Gakkai Zasshi 1994;98:389-92.
5. Read RW, Rao NA, Cunningham ET Jr. Vogt-Koyanagi-Harada disease. Curr Opin Ophthalmol 2000;11:437-42.
6. Sheu S. Update on uveomeningoencephalitides. Curr Opin Neurol 2005;18:323-9.
7. Rajendram R, Evans M, Rao NA. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin 2005;45:115-34.
8. Andreoli CM, Foster CS. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin 2006;46:111-22.
9. Damico FM, Kiss S, Young LH. Vogt-Koyanagi-Harada disease. Semi in Ophthalmol 2005;20:183-90.
10. Yamaki K, Gocho K, Sakuragi S. Pathogenesis of Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin 2002;42:13-23.
11. Yang P, Ren Y, Li B, et al. Clinical characteristics of Vogt-Koyanagi-Harada Syndrome in Chinese patients. Ophthalmol 2007;114:606-14.
12. Beniz J, Forster DJ, Lean JS, et al. Variations in clinical features of the Vogt-Koyanagi-Harada syndrome. Retina 1991;11:275-80.
13. Rubsamen PE, Gass JDM. Vogt-Koyanagi-Harada syndrome: clinical course, therapy, and long-term visual outcome. Arch Ophthalmol 1991;109:682-7.
14. Chee SP, Luu CD, Cheng CL, et al. Visual function in Vogt-Koyanagi-Harada patients. Graefe's Arch Clin Exp Ophthalmol 2005;243:785-90.
15. Bykhovskaya I, Thorne JE, Kempen JH, et al. Vogt-Koyanagi-Harada disease: clinical outcomes. Am J Ophthalmol 2005;140:674-8.
16. Nguyen NX, Küchle M, Naumann GOH. Quantification of blood-aqueous barrier breakdown after phacoemulsification in Fuchs' heterochromic uveitis. Ophthalmologica 2005;219:21-5.
17. Eter N, Spitznas M, Sbeity Z, et al. Evaluation of the blood-aqueous barrier by laser flare cell photometry following retinal cryocoagulation. Graefe's Arch Clin Exp Ophthalmol 2004;242:120-4.
18. Nguyen NX, Langenbucher A, Seitz B, et al. Blood-aqueous barrier breakdown after penetrating keratoplasty with simultaneous extracapsular cataract extraction and posterior chamber lens implantation. Graefe's Arch Clin Exp Ophthalmol 2001;239:114-7.
19. Davis JL, Dacanay LM, Holland GN, et al. Laser flare photometry and complications of chronic uveitis in children. Am J Ophthalmol 2003;135:763-71.
20. Amino K, Yamakawa R. Long-term results of out-of-the-bag intraocular lens implantation. J Cataract Refract Surg 2000;26:266-70.
21. Gonzales CA, Ladas JG, Davis JL, et al. Relationships between laser flare photometry values and complications of uveitis. Arch Ophthalmol 2001;119:1763-9.
22. Herbort CP, Guex-Crosier Y, de Ancos E, et al. Use of laser flare photometry to assess and monitor inflammation in uveitis. Ophthalmology 1997;104:64-71 [discussion 71-2].
23. Guex-Crosier Y, Pittet N, Herbort CP. Sensitivity of laser flare photometry to monitor inflammation in uveitis of the posterior segment. Ophthalmology 1995;102:613-21.
24. Guex-Crosier Y, Pittet N, Herbort CP. Evaluation of laser flare-cell photometry in the appraisal and management of intraocular inflammation in uveitis. Ophthalmology 1994;101:728-35.
25. Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001;131:647-52.
26. Yang P, Fang W, Jin H, et al. Clinical features of Chinese patients with Fuchs' syndrome. Ophthalmology 2006;113:473-80.
27. Ladas JG, Wheeler NC, Morhun PJ, et al. Laser flare-cell photometry: methodology and clinical applications. Surv Ophthalmol 2005;50:27-47.